Small molecule targeting NaV1.7 via inhibition of the CRMP2-Ubc9 interaction reduces and prevents pain chronification in a mouse model of oxaliplatin-induced neuropathic pain is a research paper published in Neurobiology of Pain (2021). On theSindex it has a DataRank of 0. It has been cited 37 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute of Neurological Disorders and Stroke
Grant: NS098772
National Institute of Neurological Disorders and Stroke
Grant: NS120663
National Institute on Drug Abuse
Grant: DA042852
National Institutes of Health
Grant: 5R01NS098772-03
CRMP2, mitochondria, and Huntington’s disease
National Institutes of Health
Grant: 3R01NS120663-01A1S2
CRMP2 Phosphorylation: A Novel Target for Alzheimer's Disease?
National Institutes of Health
Grant: 1R01DA042852-01A1
CRMP2, Nav1.7 sodium channel, and chronic pain
Saint Louis University
National Institutes of Health
FWCI
2.85
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals